Literature DB >> 20458705

A novel immunoregulatory function for IL-23: Inhibition of IL-12-dependent IFN-γ production.

Amy N Sieve1, Karen D Meeks, Suheung Lee, Rance E Berg.   

Abstract

Most studies investigating the function of IL-23 have concluded that it promotes IL-17-secreting T cells. Although some reports have also characterized IL-23 as having redundant pro-inflammatory effects with IL-12, we have instead found that IL-23 antagonizes IL-12-induced secretion of IFN-γ. When splenocytes or purified populations of T cells were cultured with IL-23, IFN-γ secretion in response to IL-12 was dramatically reduced. The impact of IL-23 was most prominent in CD8(+) T cells, but was also observed in NK and CD4(+) T cells. Mechanistically, the IL-23 receptor was not required for this phenomenon, and IL-23 inhibited signaling through the IL-12 receptor by reducing IL-12-induced signal transducer and activator of transcription 4 (STAT4) phosphorylation. IL-23 was also able to reduce IFN-γ secretion by antagonizing endogenously produced IL-12 from Listeria monocytogenes (LM)-infected macrophages. In vivo, LM infection induced higher serum IFN-γ levels and a greater percentage of IFN-γ(+)CD8(+) T cells in IL-23p19-deficient mice as compared with WT mice. This increase in IFN-γ production coincided with increased LM clearance at days 2 and 3 post-infection. Our data suggest that IL-23 may be a key factor in determining the responsiveness of lymphocytes to IL-12 and their subsequent secretion of IFN-γ.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458705      PMCID: PMC3039303          DOI: 10.1002/eji.200939759

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  54 in total

1.  Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.

Authors:  Kyle I Happel; Mingquan Zheng; Erana Young; Lee J Quinton; Euan Lockhart; Alistair J Ramsay; Judd E Shellito; Jill R Schurr; Gregory J Bagby; Steve Nelson; Jay K Kolls
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

2.  A T cell-independent mechanism of macrophage activation by interferon-gamma.

Authors:  G J Bancroft; R D Schreiber; G C Bosma; M J Bosma; E R Unanue
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

3.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.

Authors:  Daniel J Cua; Jonathan Sherlock; Yi Chen; Craig A Murphy; Barbara Joyce; Brian Seymour; Linda Lucian; Wayne To; Sylvia Kwan; Tatyana Churakova; Sandra Zurawski; Maria Wiekowski; Sergio A Lira; Daniel Gorman; Robert A Kastelein; Jonathon D Sedgwick
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

4.  Antitumor and antimetastatic activity of IL-23.

Authors:  Chia-Hui Lo; Shan-Chih Lee; Pin-Yi Wu; Wen-Yu Pan; Jui Su; Chao-Wen Cheng; Steve R Roffler; Bor-Luen Chiang; Chun-Nan Lee; Cheng-Wen Wu; Mi-Hua Tao
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

5.  Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice.

Authors:  Nico Ghilardi; Noelyn Kljavin; Qi Chen; Sophie Lucas; Austin L Gurney; Frederic J De Sauvage
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

Review 6.  The biology of IL-12: coordinating innate and adaptive immune responses.

Authors:  Wendy T Watford; Masato Moriguchi; Akio Morinobu; John J O'Shea
Journal:  Cytokine Growth Factor Rev       Date:  2003-10       Impact factor: 7.638

7.  Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge.

Authors:  Hiromasa Hamada; Maria de la Luz Garcia-Hernandez; Joyce B Reome; Sara K Misra; Tara M Strutt; Kai K McKinstry; Andrea M Cooper; Susan L Swain; Richard W Dutton
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

8.  Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist.

Authors:  S Gillessen; D Carvajal; P Ling; F J Podlaski; D L Stremlo; P C Familletti; U Gubler; D H Presky; A S Stern; M K Gately
Journal:  Eur J Immunol       Date:  1995-01       Impact factor: 5.532

9.  Specific immunity to Listeria monocytogenes in the absence of IFN gamma.

Authors:  J T Harty; M J Bevan
Journal:  Immunity       Date:  1995-07       Impact factor: 31.745

10.  Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen.

Authors:  Rance E Berg; Emily Crossley; Sean Murray; James Forman
Journal:  J Exp Med       Date:  2003-11-17       Impact factor: 14.307

View more
  24 in total

Review 1.  Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer.

Authors:  Juming Yan; Mark J Smyth; Michele W L Teng
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-07-02       Impact factor: 10.005

Review 2.  IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS.

Authors:  Govardhana Rao Yannam; Tanuja Gutti; Larisa Y Poluektova
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-24       Impact factor: 4.147

3.  Adoptively transferred donor IL-17-producing CD4+ T cells augment, but IL-17 alleviates, acute graft-versus-host disease.

Authors:  Yifeng Cai; Shoubao Ma; Yuejun Liu; Huanle Gong; Qiao Cheng; Bo Hu; Yan Wu; Xiao Yu; Chen Dong; Kai Sun; Depei Wu; Haiyan Liu
Journal:  Cell Mol Immunol       Date:  2016-10-17       Impact factor: 11.530

4.  Regulation of IL-17A and implications for TGF-β1 comodulation of airway smooth muscle remodeling in severe asthma.

Authors:  Jon M Evasovic; Cherie A Singer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-02-27       Impact factor: 5.464

5.  Immunological mechanism of low-dose priming radiation resistance in walker-256 tumor model mice.

Authors:  Li Feng; Ling Qin; Dan Guo; Daping Deng; Feng Lu; Hailiang Li; Narisu Bao; Xiting Yang; Hongyu Ding; Jianguo Li
Journal:  Exp Ther Med       Date:  2017-08-21       Impact factor: 2.447

6.  IL-23 modulated myelin-specific T cells induce EAE via an IFNγ driven, IL-17 independent pathway.

Authors:  Mark A Kroenke; Benjamin M Segal
Journal:  Brain Behav Immun       Date:  2010-10-15       Impact factor: 7.217

7.  MicroRNA-155 regulates host immune response to postviral bacterial pneumonia via IL-23/IL-17 pathway.

Authors:  Amy Podsiad; Theodore J Standiford; Megan N Ballinger; Richard Eakin; Pauline Park; Steven L Kunkel; Bethany B Moore; Urvashi Bhan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-11-20       Impact factor: 5.464

8.  Homeostatic regulation of Salmonella-induced mucosal inflammation and injury by IL-23.

Authors:  Muyiwa Awoniyi; Samuel I Miller; Christopher B Wilson; Adeline M Hajjar; Kelly D Smith
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

9.  Differential use of TLR2 and TLR9 in the regulation of immune responses during the infection with Trypanosoma cruzi.

Authors:  Humberto D Gravina; Lis Antonelli; Ricardo T Gazzinelli; Catherine Ropert
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

10.  ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression.

Authors:  Helen Sheldon; Esther Bridges; Ildefonso Silva; Massimo Masiero; David M Favara; Dian Wang; Russell Leek; Cameron Snell; Ioannis Roxanis; Mira Kreuzer; Uzi Gileadi; Francesca M Buffa; Alison Banham; Adrian L Harris
Journal:  Mol Cancer Res       Date:  2021-08-04       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.